United Kingdom · Question · Written question
HL HL1922
Coronavirus: Ivermectin
Introduced
12 July 2021
Last action
20 July 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
20 July 2021
Summary
To ask Her Majesty's Government what consideration they have given to the (1) licensing, and (2) use, of Ivermectin in both the (a) treatment, and (b) prevention, of COVID-19.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
12 July 2021
Written question
To ask Her Majesty's Government what consideration they have given to the (1) licensing, and (2) use, of Ivermectin in both the (a) treatment, and (b) prevention, of COVID-19.
Source: Lords
20 July 2021
Answer
The Department is closely monitoring the evidence on the case for using ivermectin for the treatment and prevention of COVID-19. Licensing of ivermectin is dependent on application to the Medicines and Healthcare products Regulatory Agency for authorisati...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-07-12/HL1922
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1345661
- uk · wq-1345661 · source updated 20 July 2021